MYDA Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-28,000
| Closed | -$2.04M | – | 112 |
|
|
2023
Q3 | $2.04M | Buy |
+28,000
| New | +$2.04M | 0.66% | 32 |
|
|
2022
Q3 | – | Sell |
-41,000
| Closed | -$3.05M | – | 189 |
|
|
2022
Q2 | $3.05M | Buy |
+41,000
| New | +$3.05M | 0.85% | 19 |
|
|
2022
Q1 | – | Sell |
-34,000
| Closed | -$3.81M | – | 255 |
|
|
2021
Q4 | $3.81M | Buy |
34,000
+22,000
| +183% | +$2.46M | 1.02% | 25 |
|
|
2021
Q3 | $1.51M | Buy |
+12,000
| New | +$1.51M | 0.42% | 52 |
|
|
2021
Q2 | – | Sell |
-10,000
| Closed | -$1.36M | – | 321 |
|
|
2021
Q1 | $1.36M | Buy |
+10,000
| New | +$1.36M | 0.38% | 73 |
|
|
2020
Q1 | – | Sell |
-18,000
| Closed | -$1.71M | – | 131 |
|
|
2019
Q4 | $1.71M | Buy |
+18,000
| New | +$1.71M | 0.75% | 28 |
|
|
2019
Q1 | – | Sell |
-10,000
| Closed | -$718K | – | 102 |
|
|
2018
Q4 | $718K | Buy |
+10,000
| New | +$718K | 1.23% | 19 |
|
|
2018
Q1 | – | Sell |
-23,000
| Closed | -$1.95M | – | 147 |
|
|
2017
Q4 | $1.95M | Buy |
+23,000
| New | +$1.95M | 0.87% | 13 |
|